Skip to main content
Premium Trial:

Request an Annual Quote

StageZero Life Sciences Closes C$1.87M Private Financing

NEW YORK – Molecular diagnostic company StageZero Life Sciences announced on Thursday that it has closed a C$1.87 million (US$1.46 million) private financing with an unnamed institutional investor.

The proceeds from the financing will be used to accelerate the firm's global growth strategy and support the commercialization of the Aristotle test and AVRT telehealth platform, the company said in a statement.

The Toronto-based company issued 10 million common shares and warrants at a purchase price of C$.187 per share and associated warrant for the private placement, it said. Each warrant entitles the holder to purchase one common share at an exercise price of C$.2206 per common share for up to four years after the issuance date. H.C. Wainwright acted as the exclusive placement agent for the financing.

"With the formal launch of AVRT in the US now underway and the planned introductions in Canada and the UK, this additional financing will allow us to accelerate adoption by expanding promotion," James Howard-Tripp, chairman and CEO of StageZero Life Sciences, said in a statement.

The firm's Aristotle blood test uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Sentinel Principle, StageZero's technology platform. The company also offers its ColonSentry, BreastSentry, and Prostate Health Index tests.

StageZero closed a C$4.2 million private placement in November of last year and a C$7.2 million public offering in December 2020.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.